Dyngo-4a

Catalog No.S7163 Batch:S716301

Print

Technical Data

Formula

C18H14N2O5

Molecular Weight 338.31 CAS No. 1256493-34-1
Solubility (25°C)* In vitro DMSO 67 mg/mL (198.04 mM)
Ethanol 1 mg/mL (2.95 mM)
Water Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Dyngo-4a is a potent dynamin inhibitor with IC50 of 0.38 μM, 1.1 μM, and 2.3 μM for DynI (brain), DynI (rec), and DynII (rec), respectively.
Targets
DynI (brain) [1] DynI (rec) [1] DynII (rec) [1]
0.38 μM 1.1 μM 2.3 μM
In vitro Dyngo-4a inhibits dynamin-dependent endocytosis of transferrin in multiple cell types with IC₅₀ of 5.7 μM, and reduces synaptic vesicle endocytosis and activity-dependent bulk endocytosis in cultured neurons and synaptosomes. [1] In motor nerve terminals and cultured hippocampal neurons, Dyngo-4a blocks Alexa Fluor 488-BoNT/A-Hc internalization. [2] In Drosophila S2R+ cells, Dyngo-4a causes a decrease in the level of Armadillo/β-catenin. [3]

Protocol (from reference)

Kinase Assay:

[1]

  • Dynamin GTPase assay

    Dynamin I activity is measured in its SAI activity state or is stimulated by three different methods. As each stimulus activates dynamin to different extents, each assay requires different dynamin concentrations. First, maximal dynamin activity is stimulated by sonicated PS liposomes. Purified dynamin I (10–20 nM, diluted in: 6 mM Tris–HCl, 20 mM NaCl and 0.01% Tween 80, pH 7.4) is incubated in 96-well plates in GTPase buffer (5 mM Tris–HCl, 10 mM NaCl, 2 mM Mg2+, 0.05% Tween 80, pH 7.4, 1 µg/mL leupeptin and 0.1 mM PMSF) and GTP 0.3 mM in the presence of test compound for 30 min at 37°C in a final assay volume of 150 μL. Reactions are terminated with 10 μL of 0.5 M ethylenediaminetetraacetic acid (EDTA) pH 7.4 and Malachite Green solution (40 μL: 2% w/v ammonium molybdate tetrahydrate, 0.15% w/v malachite green and 4 M HCl) is added for 5 min. Second, dynamin (20 nM) is stimulated by 10 µg/mL of taxol-stabilized preformed bovine brain microtubules using the same protocol. Third, dynamin I (50 nM) is stimulated by 1 μM of recombinant grb2, a SH3-containing protein that stimulates dynamin about 5–10 times less efficiently than liposomes or microtubules. Finally, dynamin (500 nM) SAI activity is measured using high concentrations of dynamin, which promote its cooperative self-assembly into rings (but not helices). The final DMSO concentration in the GTPase or endocytosis assays is at most 3.3 or 1%, respectively, but typically is at 1%. The GTPase assay for dynamin I is unaffected by DMSO up to 3.3%. Compounds are dissolved as 30 mM stocks in 100% DMSO. These stock solutions can be stored at −20°C for several months. Compounds are subsequently diluted into solutions of 50% DMSO made up in 20 mM Tris–HCl pH 7.4 and diluted again into the final assay. For analysis of the kinetics of 4a inhibition, dynamin I at a final concentration of 17 nM is incubated with GTPase buffer containing PS (2 µg/mL) and varying amounts of GTP (50–250 μM) in the presence of 4a at a concentration range between 0.5 and 6 μM. The reaction is stopped after 30 min by addition of EDTA (0.5 mM, pH 7.4). Curves are generated using the Michaelis–Menten equation v = Vmax[S]/(Km + [S]), where S is the GTP substrate. After the Vmax and Km values were determined, the data were transformed using the Lineweaver–Burke equation, 1/v = 1/Vmax + (Km/Vmax)(1/[S]). Assay conditions are based on the dynamin I assay but contained modifications. Recombinant dynamin II is used at 50 nM, stimulated by 10 µg/mL PS. The GTPase reaction is allowed to occur for 90 min at 37°C before termination.

Cell Assay:

[5]

  • Cell lines

    αT3–1 or LβT2 cells

  • Concentrations

    30 μM

  • Incubation Time

    30 minutes

  • Method

    αT3-1 or LβT2 cells (2 × 106) were grown overnight in a 6-well culture dish and then serum starved for 2–4 hours. Cells were pretreated with either vehicle (0), dynasore (80μM), or dyngo (30μM) for 30 minutes. For dose-response studies, indicated doses of dynasore were used for a 30-minute pretreatment. After pretreatment, cells were treated with 0 or GnRHa (10 nM) for 10 minutes. Cells were then washed twice in PBS, lysed in radio-immunoprecipitation assay (RIPA) buffer and subjected to SDS-PAGE (acrylamide:bis-acrylamide ratio of 29:1) and electroblotted to polyvinylidene difluoride membranes.

Animal Study:

[4]

  • Animal Models

    Female CD-1 mice

  • Dosages

    30 mg/kg

  • Administration

    i.p.

Customer Product Validation

Data from [Data independently produced by , , Cell Commun Signal, 2018, 16(1):40]

Data from [Data independently produced by , , J Immunol, 2018, 200(3):997-1007]

Data from [Data independently produced by , , Int J Biochem Cell Biol, 2018, 105:1-12]

Selleck's Dyngo-4a has been cited by 26 publications

Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks [ Immunity, 2024, 57(2):287-302.e12] PubMed: 38354704
RAB22A sorts epithelial growth factor receptor (EGFR) from early endosomes to recycling endosomes for microvesicles release [ J Extracell Vesicles, 2024, 13(7):e12494] PubMed: 39051763
Peptide nanocarriers co-delivering an antisense oligonucleotide and photosensitizer elicit synergistic cytotoxicity [ J Colloid Interface Sci, 2024, 664:338-348] PubMed: 38479270
CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer [ Cancer Lett, 2024, 590:216845] PubMed: 38589004
Gut Bacteria-derived Membrane Vesicles Induce Colonic Dysplasia by Inducing DNA Damage in Colon Epithelial Cells [ Cell Mol Gastroenterol Hepatol, 2024, S2352-345X(24)00010-9] PubMed: 38309455
Evidence for a clathrin-independent endocytic pathway for APP internalization in the neuronal somatodendritic compartment [ Cell Rep, 2023, 42(7):112774] PubMed: 37450368
Endocytosis inhibitors block SARS-CoV-2 pseudoparticle infection of mink lung epithelium [ Front Microbiol, 2023, 14:1258975] PubMed: 38033586
Irreversible tyrosine kinase inhibitors induce the endocytosis and downregulation of ErbB2 [ Biochem Biophys Rep, 2023, 34:101436] PubMed: 36824069
Establishing a Disease-in-a-Dish Model to Study SARS-CoV-2 Infection During Prenatal Development [ Curr Protoc, 2023, 3(4):e759] PubMed: 37098759
Low-dose metformin targets the lysosomal AMPK pathway through PEN2 [ Nature, 2022, 603(7899):159-165] PubMed: 35197629

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.